Timuçin Çil

2.7k total citations
62 papers, 462 citations indexed

About

Timuçin Çil is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Timuçin Çil has authored 62 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Timuçin Çil's work include Gastric Cancer Management and Outcomes (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Timuçin Çil is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Timuçin Çil collaborates with scholars based in Türkiye, China and United Kingdom. Timuçin Çil's co-authors include Abdullah Altıntaş, Orhan Ayyıldız, Semir Paşa, Abdurrahman Işıkdoğan, Kaplan Ma, Nilüfer Okur, Ramazan Danış, Yekta Tüzün, Mithat Bahçeci and Nurten Akdeniz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Cancer.

In The Last Decade

Timuçin Çil

48 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timuçin Çil Türkiye 14 162 119 111 90 69 62 462
Abdullah Altıntaş Türkiye 14 199 1.2× 89 0.7× 53 0.5× 81 0.9× 88 1.3× 30 446
P. Reinecke Germany 10 149 0.9× 76 0.6× 83 0.7× 124 1.4× 48 0.7× 35 418
Syed A. Mehdi United States 14 66 0.4× 213 1.8× 172 1.5× 89 1.0× 45 0.7× 36 494
Sylvie Cointe France 10 99 0.6× 52 0.4× 118 1.1× 39 0.4× 41 0.6× 15 523
Claire Barro France 12 195 1.2× 49 0.4× 50 0.5× 152 1.7× 64 0.9× 29 601
Amr El Weshi Saudi Arabia 12 58 0.4× 154 1.3× 121 1.1× 110 1.2× 39 0.6× 17 515
Philippe Tron France 10 90 0.6× 170 1.4× 63 0.6× 116 1.3× 74 1.1× 10 391
Nicholas Sauter United States 10 176 1.1× 107 0.9× 394 3.5× 107 1.2× 92 1.3× 22 805
Reena Ramsaroop South Africa 12 63 0.4× 35 0.3× 138 1.2× 203 2.3× 45 0.7× 27 509
Stephen Jarrett United Kingdom 9 138 0.9× 104 0.9× 72 0.6× 57 0.6× 409 5.9× 9 575

Countries citing papers authored by Timuçin Çil

Since Specialization
Citations

This map shows the geographic impact of Timuçin Çil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timuçin Çil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timuçin Çil more than expected).

Fields of papers citing papers by Timuçin Çil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timuçin Çil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timuçin Çil. The network helps show where Timuçin Çil may publish in the future.

Co-authorship network of co-authors of Timuçin Çil

This figure shows the co-authorship network connecting the top 25 collaborators of Timuçin Çil. A scholar is included among the top collaborators of Timuçin Çil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timuçin Çil. Timuçin Çil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Rha, Sun Young, Lucjan Wyrwicz, Yuxian Bai, et al.. (2024). Pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study.. Journal of Clinical Oncology. 42(16_suppl). 4045–4045. 5 indexed citations
6.
7.
Çil, Timuçin, Kubilay Demırağ, Kutay Demirkan, et al.. (2023). KEPAN Enteral Beslenme (EB) Rehberi. 5. 1–29. 1 indexed citations
8.
9.
Sungur, Mehmet Alı, et al.. (2021). Efficacy of preoperative neutrophil-to-lymphocyte ratio in determining lymph node metastases in testicular cancer. SHILAP Revista de lepidopterología. 46(3). 1070–1076. 1 indexed citations
10.
Duman, Berna Bozkurt, et al.. (2021). Male Breast Cancer: Clinical, Demographical, and Pathological Features in a Cohort of 41 Patients. Cureus. 13(9). e17812–e17812. 2 indexed citations
11.
Küçüköner, Mehmet, Abdurrahman Işıkdoğan, Kaplan Ma, et al.. (2012). Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?. Współczesna Onkologia. 5(5). 416–419. 4 indexed citations
12.
Çil, Timuçin, Abdullah Altıntaş, Semir Paşa, Zuhat Urakçı, & Abdurrahman Işıkdoğan. (2009). Breast carcinoma metastasis to the tail of pancreas. SHILAP Revista de lepidopterología. 5(4). 228–230. 1 indexed citations
13.
Çil, Timuçin, Abdullah Altıntaş, Yusuf Tamam, Esra Battaloğlu, & Abdurrahman Işıkdoğan. (2009). Low Dose Vincristine-induced Severe Polyneuropathy in a Hodgkin Lymphoma Patient. Journal of Pediatric Hematology/Oncology. 31(10). 787–789. 20 indexed citations
14.
Paşa, Semir, Abdullah Altıntaş, Timuçin Çil, et al.. (2008). Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?. International Journal of Infectious Diseases. 13(1). e19–e22. 4 indexed citations
15.
Paşa, Semir, et al.. (2008). A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab. Journal of Thrombosis and Thrombolysis. 27(2). 220–222. 6 indexed citations
16.
Çil, Timuçin, Abdullah Altıntaş, & Abdurrahman Işıkdoğan. (2008). Rhabdomyosarcoma Presenting With Destructive Large Lesion of the Face. Southern Medical Journal. 101(1). 104–105. 3 indexed citations
17.
Paşa, Semir, Mehmet Küçüköner, Yekta Tüzün, et al.. (2008). The effects of nonsteroidal anti-inflammatory drugs on platelet function and severity of upper gastrointestinal haemorrhage. Journal of Thrombosis and Thrombolysis. 28(1). 83–89. 6 indexed citations
18.
Tüzün, Yekta, et al.. (2007). Türkiye’nin Güneydoğusundaki akut zehirlenme olgularının profili. 34(3). 195–198. 3 indexed citations
19.
Danış, Ramazan, et al.. (2007). Thrombosis of temporal artery and renal vein in Kimura disease related nephrotic syndrome. Journal of Thrombosis and Thrombolysis. 27(1). 115–118. 13 indexed citations
20.
Altıntaş, Abdullah, et al.. (2007). Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis. Leukemia & lymphoma. 48(10). 1981–1987. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullah Altıntaş Breakdown of academic impact, for papers by P. Reinecke Breakdown of academic impact, for papers by Syed A. Mehdi Breakdown of academic impact, for papers by Sylvie Cointe Breakdown of academic impact, for papers by Claire Barro Breakdown of academic impact, for papers by Amr El Weshi Breakdown of academic impact, for papers by Philippe Tron Breakdown of academic impact, for papers by Nicholas Sauter Breakdown of academic impact, for papers by Reena Ramsaroop Breakdown of academic impact, for papers by Stephen Jarrett
Rankless by CCL
2026